# Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)

> **NCT00636493** · EARLY_PHASE1 · COMPLETED · sponsor: **Glenn Jaffe** · enrollment: 30 (actual)

## Conditions studied

- Retinal Vein Occlusion

## Interventions

- **DEVICE:** fluocinolone acetonide (Retisert Implant)

## Key facts

- **NCT ID:** NCT00636493
- **Lead sponsor:** Glenn Jaffe
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00636493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00636493, "Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00636493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*